ZA200408111B - Treatment of gastroparesis. - Google Patents

Treatment of gastroparesis.

Info

Publication number
ZA200408111B
ZA200408111B ZA200408111A ZA200408111A ZA200408111B ZA 200408111 B ZA200408111 B ZA 200408111B ZA 200408111 A ZA200408111 A ZA 200408111A ZA 200408111 A ZA200408111 A ZA 200408111A ZA 200408111 B ZA200408111 B ZA 200408111B
Authority
ZA
South Africa
Prior art keywords
gastroparesis
treatment
Prior art date
Application number
ZA200408111A
Other languages
English (en)
Inventor
Joseph Anthony Jakubowski
Thurman Dwight Mckinney
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA200408111B publication Critical patent/ZA200408111B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA200408111A 2002-04-10 2004-10-07 Treatment of gastroparesis. ZA200408111B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37165002P 2002-04-10 2002-04-10

Publications (1)

Publication Number Publication Date
ZA200408111B true ZA200408111B (en) 2005-10-07

Family

ID=29250714

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200408111A ZA200408111B (en) 2002-04-10 2004-10-07 Treatment of gastroparesis.

Country Status (18)

Country Link
US (1) US20050164925A1 (fr)
EP (1) EP1496924A4 (fr)
JP (1) JP2005530732A (fr)
KR (1) KR20040098063A (fr)
CN (1) CN1735423A (fr)
AU (1) AU2003220403A1 (fr)
BR (1) BR0308904A (fr)
CA (1) CA2480858A1 (fr)
EA (1) EA200401345A1 (fr)
EC (1) ECSP045345A (fr)
HR (1) HRP20040939A2 (fr)
IL (1) IL164266A0 (fr)
MX (1) MXPA04009929A (fr)
NO (1) NO20044815L (fr)
NZ (1) NZ535684A (fr)
PL (1) PL373658A1 (fr)
WO (1) WO2003087139A2 (fr)
ZA (1) ZA200408111B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
TW200522976A (en) * 2003-09-19 2005-07-16 Novo Nordisk As Novel plasma protein affinity tags
WO2005027978A2 (fr) * 2003-09-19 2005-03-31 Novo Nordisk A/S Nouveaux derives de glp-1
WO2006018851A2 (fr) 2004-08-18 2006-02-23 Metacure Ltd. Suivi, analyse et regulation des habitudes alimentaires
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
EP1880298B1 (fr) 2005-02-17 2016-07-13 Metacure Limited Chargeur dote de moyens de transfert de donnees
TWI362392B (en) 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
MX2007011307A (es) 2005-03-18 2007-10-08 Novo Nordisk As Compuestos de glp-1 extendidos.
WO2006102626A2 (fr) * 2005-03-24 2006-09-28 Metacure Nv Conducteurs sans fil pour applications aux tractus gastro-intestinal
WO2007080595A2 (fr) 2006-01-12 2007-07-19 Metacure N.V. Ensembles d'électrodes, outils et procédés pour une implantation sur une paroi gastrique
EP1890763A4 (fr) 2005-06-02 2017-05-03 Metacure Limited Implantation de fils gi
US8442841B2 (en) * 2005-10-20 2013-05-14 Matacure N.V. Patient selection method for assisting weight loss
US8295932B2 (en) 2005-12-05 2012-10-23 Metacure Limited Ingestible capsule for appetite regulation
WO2007124461A2 (fr) * 2006-04-20 2007-11-01 Amgen Inc. Composés de glp-1
AU2012203915B9 (en) * 2006-04-20 2014-10-09 Amgen Inc. GLP-1 compounds
US8417329B2 (en) * 2007-05-09 2013-04-09 Metacure Ltd. Analysis and regulation of food intake
US8423130B2 (en) * 2008-05-09 2013-04-16 Metacure Limited Optimization of thresholds for eating detection
CN102112157B (zh) 2008-08-06 2013-05-29 诺沃-诺迪斯克保健股份有限公司 具有延长的体内效能的缀合蛋白
JP5816097B2 (ja) 2009-01-22 2015-11-18 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
EP2461831B1 (fr) 2009-08-06 2018-11-21 Novo Nordisk Health Care AG Hormones de croissance ayant une efficacité in vivo prolongée
WO2011017554A2 (fr) * 2009-08-07 2011-02-10 Mannkind Corporation Composition glp-1 val (8) et procédé de traitement de la dyspepsie fonctionnelle et/ou du syndrome du côlon irritable
JP5980689B2 (ja) 2010-01-22 2016-08-31 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
SI2525834T1 (sl) 2010-01-22 2019-10-30 Novo Nordisk Healthcare Ag Rastni hormoni s podaljšano in vivo učinkovitostjo
WO2011092710A2 (fr) * 2010-02-01 2011-08-04 Metacure Limited Thérapie électrique gastro-intestinale
EP2565202A4 (fr) 2010-04-30 2013-10-30 Sanwa Kagaku Kenkyusho Co Peptide permettant d'améliorer la stabilité in vivo d'une substance physiologiquement active ou analogues et substance physiologiquement active et analogues présentant une amélioration de la stabilité in vivo
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
EP2934569A1 (fr) 2012-12-21 2015-10-28 Sanofi Dérivés de l'exendine 4
WO2014166836A1 (fr) 2013-04-05 2014-10-16 Novo Nordisk A/S Formulation de composés d'hormone de croissance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268343B1 (en) * 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
US5981488A (en) * 1997-03-31 1999-11-09 Eli Lillly And Company Glucagon-like peptide-1 analogs
IL142707A0 (en) * 2000-04-27 2002-03-10 Pfizer Prod Inc Methods of treating obesity using a neurotensin receptor ligand

Also Published As

Publication number Publication date
WO2003087139A3 (fr) 2004-01-08
US20050164925A1 (en) 2005-07-28
EP1496924A2 (fr) 2005-01-19
WO2003087139A2 (fr) 2003-10-23
NO20044815L (no) 2005-01-07
PL373658A1 (en) 2005-09-05
ECSP045345A (es) 2006-04-19
EP1496924A4 (fr) 2007-05-30
EA200401345A1 (ru) 2005-08-25
KR20040098063A (ko) 2004-11-18
CA2480858A1 (fr) 2003-10-23
NZ535684A (en) 2006-03-31
MXPA04009929A (es) 2006-03-10
CN1735423A (zh) 2006-02-15
JP2005530732A (ja) 2005-10-13
HRP20040939A2 (en) 2004-12-31
IL164266A0 (en) 2005-12-18
BR0308904A (pt) 2005-05-03
AU2003220403A1 (en) 2003-10-27

Similar Documents

Publication Publication Date Title
ZA200408111B (en) Treatment of gastroparesis.
IL218909A0 (en) Treatment of diabetes
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
GB0112343D0 (en) Well treatment
GB0201674D0 (en) Medical treatment
HK1078784A1 (en) Therapeutic treatment
GB0223367D0 (en) Therapeutic treatment
GB0218879D0 (en) Medical treatment
GB0213869D0 (en) The treatment of pain
GB2388557B (en) Treatment system
GB0210464D0 (en) Therapeutic treatment
GB0221157D0 (en) Novel treatment
GB0217493D0 (en) Novel methods of treatment
GB0223650D0 (en) Psoriasis treatment
GB0221712D0 (en) Methods of treatment
AU2003292367A8 (en) Soil treatment
GB0213198D0 (en) Method of treatment
GB0211297D0 (en) Pain treatment
AP2004002980A0 (en) The treatment of lipodystrophy.
GB0207091D0 (en) Method of treatment
GB0213493D0 (en) Treatment
GB0220820D0 (en) Treatment
GB0218818D0 (en) Novel treatment
GB0208783D0 (en) Methods of treatment